Nephrogenic Fibrosing Dermopathy
"Nephrogenic Fibrosing Dermopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.
| Descriptor ID |
D054989
|
| MeSH Number(s) |
C17.800.553 C23.550.355.550
|
| Concept/Terms |
Nephrogenic Fibrosing Dermopathy- Nephrogenic Fibrosing Dermopathy
- Dermopathies, Nephrogenic Fibrosing
- Dermopathy, Nephrogenic Fibrosing
- Fibrosing Dermopathies, Nephrogenic
- Fibrosing Dermopathy, Nephrogenic
- Nephrogenic Fibrosing Dermopathies
- Nephrogenic Systemic Fibrosis
- Fibroses, Nephrogenic Systemic
- Fibrosis, Nephrogenic Systemic
- Nephrogenic Systemic Fibroses
- Systemic Fibroses, Nephrogenic
- Systemic Fibrosis, Nephrogenic
|
Below are MeSH descriptors whose meaning is more general than "Nephrogenic Fibrosing Dermopathy".
Below are MeSH descriptors whose meaning is more specific than "Nephrogenic Fibrosing Dermopathy".
This graph shows the total number of publications written about "Nephrogenic Fibrosing Dermopathy" by people in this website by year, and whether "Nephrogenic Fibrosing Dermopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nephrogenic Fibrosing Dermopathy" by people in Profiles.
-
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use. Tex Heart Inst J. 2022 05 01; 49(3).
-
Risks and Benefits of Gadolinium-Based Contrast-Enhanced MRI. Semin Ultrasound CT MR. 2020 Apr; 41(2):170-182.
-
Safety of Contrast Material Use in Children. Magn Reson Imaging Clin N Am. 2017 Nov; 25(4):779-785.
-
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report. Br J Radiol. 2014 Oct; 87(1042):20140307.
-
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014 Feb; 44(2):173-80.
-
Lollipop lesions in nephrogenic systemic fibrosis mimicking a deep fungal infection. J Cutan Pathol. 2012 Nov; 39(11):981-4.
-
Nephrogenic systemic fibrosis: a concise review for cardiologists. Tex Heart Inst J. 2010; 37(5):508-15.